Relationship between alpha-1 antitrypsin deficient genotypes S and Z and lung cancer in Jordanian lung cancer patients

Saudi Medical Journal

Volumn 27, Issue 2, 2006, Pages 181-184

  El Akawi, Zeyad J ^a   Nusier, Mohamad K ^a   Zoughool, Foad E ^a  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ADULT; ALLELE; ARTICLE; BRONCHUS BIOPSY; CANCER SCREENING; CARCINOGENESIS; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; GENE IDENTIFICATION; GENETIC SCREENING; GENOTYPE; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JORDAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; ARABS; HUMANS; JORDAN; LUNG NEOPLASMS; PROTEASE INHIBITORS;

EID: 33644556197     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Suzuki K, Deyashiki Y. Plasma serine proteinase inhibitor (SERPIN) super family proteins. Tanpakushitsu Kakusan Koso 1989; 34: 949-962.
2. Sandford AJ, Weir TD, Spinelli JJ, Pare PD. Z and S mutations of the α1-antitrypsin gene and the risk of chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 1999; 20: 287-291.
3. Coakley RJ, Taggart C, O'Neill S, McElvaney NG. Alpha 1-antitrypsin deficiency: biological answers to clinical questions. Am J Med Sci 2001; 321: 33-41.
4. Taggart C, Cervantes-Laurean D, Kim G, McElvaney NG, Wehr N, Moss J, et al. Oxidation of either methionine 351 or methionine 358 in α1-antitrypsin causes loss of anti-neutrophil elastase activity. J Biol Chem 2000; 275: 27258-27265.
5. Carrell RW, Jeppsson JO, Laurell CB, Brennan SO, Owen MC, Vaughan L, et al. Structure and variation of human α1-antitrypsin. Nature 1982; 298: 329-334.
6. Crystal RG, Brantly ML, Hubbard RC, Curiel DT, States DJ, Holmes MD. The α1-antitrypsin gene and its mutations. Clinical consequences and strategies for therapy. Chest 1989; 95: 196-208.
7. De Tommaso AM, Rossi CL, Escanhoela CA, Serra HG, Bertuzzo CS, Hessel G. Diagnosis of α1-antitrypsin deficiency by DNA analysis of children with liver disease. Arq Gastroenterol 2001; 38: 63-68.
8. De Serres FJ. Alpha-1 antitrypsin deficiency is not a rare disease but a disease that is rarely diagnosed. Environ Health Perspect 2003; 111: 1851-1854.
9. Sun Z, Yang P. Role of imbalance between neutrophil elastase and α1-antitrypsin in cancer development and progression. Lancet Oncol 2004; 5: 182-190.
10. Yang P, Wentzlaff KA, Katzmann JA, Marks RS, Allen MS, Lesnick TG, et al. Alpha1-antitrypsin deficiency allele carriers among lung cancer patients. Cancer Epidemiol Biomarkers Prev 1999; 8: 461-465.
11. Daddi G, Mancini PA, Parola D, Contini A. Alpha1-antitrypsin increase in lung cancer. Boll Ist Sieroter Milan 1976; 55: 510-512.
12. Clerc M, Le Bras M, Loubiere R, Houvet D. Primary liver carcinoma: deficiency of α1-antitrypsin. Nouv Presse Med 1977; 6: 3061-3064.
13. Latner AL, Turner GA, Lamin MM. Plasma α1-antitrypsin levels in early and late carcinoma of the cervix. Oncology 1976; 33: 12-14.
14. Benkmann HG, Hanssen HP, Ovenbeck R, Goedde HW. Distribution of α-1-antitrypsin and haptoglobin phenotypes in bladder cancer patients. Hum Hered 1987; 37: 290-293.
15. Ordonez NG, Manning JT Jr, Hanssen G. Alpha-1-antitrypsin in islet cell tumors of the pancreas. Am J Clin Pathol 1983; 80: 277-282.
16. Yamaguchi N, Yamamura Y, Koyama K, Ohtsuji E, Imanishi J, Ashihara T. Characterization of new human pancreatic cancer cell lines which propagate in a protein-free chemically defined medium. Cancer Res 1990; 50: 7008-7014.
17. Butterworth DM, Haboubi NY, Lupton EW. Mixed mesonephric adenocarcinoma and transitional cell carcinoma of the bladder. Histopathology 1990; 16: 601-604.
18. Chomette G, Auriol M, Vaillant JM, Kasai T, Niwa M, Mori M. An immunohistochemical study of the distribution of lysozyme, lactoferrin, α1-antitrypsin and α1-antichymotrypsin in salivary adenoid cystic carcinoma. Pathol Res Pract 1991; 187: 1001-1008.
19. Dictor M. Alpha 1-antitrypsin in a malignant mixed mesodermal tumor of the ovary. Am J Surg Pathol 1981; 5: 543-550.
20. Rees ED, Hollingsworth JW, Hoffman TR, Black H, Hearn TL. Smoking and disease: effect on serum antitrypsin in hospitalized patients. Arch Environ Health 1975; 30: 402-408.
21. Bata J, Colobert L, Biron A, Brune J. Study of various serum proteins in lung cancer. Immunoglobulins A, G, M, haptoglobin, α1-antitrypsin, α2-macroglobulin. Ann Biol Clin Paris 1977; 35: 297-303.
22. Marks RS, Taylor WR, Aubry MC, Ebbert JO, Sun Z, Bamlet WR, et al. Alpha-1 antitrypsin and neutrophil elastase imbalance and lung cancer risk. Chest 2005; 128: 445-452.
23. Dahl M, Tybjaerg-Hansen A, Lange P, Vestbo J, Nordestgaard BG. Change in lung function and morbidity from chronic obstructive pulmonary disease in α1-antitrypsin MZ heterozygotes: A longitudinal study of the general population. Ann Intern Med 2002; 136: 270-279.
24. De Serres FJ. Worldwide racial and ethnic distribution of α1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys. Chest 2002; 122: 1818-1829.
25. Komboh M. Biochemical and genetic aspects of human serum α-1 protease inhibitor protein. Dis Markers 1985; 3: 135-154.
26. Christopher W, Pang C, Priscilla M, Chang-Hong Y, Bharathi G. Rapid screening for α1-antitrypsin Z and S mutations. Clin Chem 1997; 43: 403-404.
27. De la Roza C, Rodriguez-Frias F, Lara B, Vidal R, Jardi R, Miravitlles M. Results of a case-detection program for α1-antitrypsin deficiency in COPD patients. Eur Respir J 2005; 26: 616-622.
28. Harris CC, Cohen MH, Connor R, Primack A, Saccomanno G, Talamo RC. Serum α1-antitrypsin in patients with lung cancer or abnormal sputum cytology. Cancer 1976; 38: 1655-1657.